Floatz logo

Nerve Growth Factor

Traumatic Brain Injury

Jinling Hospital, ChinaPhase 2Dormant
CCC
54/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
73/ 100

Competitive context

93 Active assets in the Traumatic Brain Injury cohort.

Asset / SponsorPhaseRating
MELATONIN
Children's National Research Institute
Phase 4BBB
Valproic Acid
Northwestern University
Phase 4BBB
PROPRANOLOL
Tanta University
Phase 4BBB
N-Acetyl-L-Cysteine
HonorHealth Research Institute
Phase 2BB
NEPENTHE
Henry M. Jackson Foundation for the Advancement of Military Medicine
Phase 4BB

View all 50 →

Same molecule, other indications

Nerve Growth Factor is also rated in:

DysphagiaDormant
BB
Indicative ·
65 / 100
View asset →
ischemic strokeDormant
B
Indicative ·
58 / 100
View asset →
amyotrophic lateral sclerosisDormant
CCC
Indicative ·
52 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →